Liquid chromatography-tandem mass spectrometric assay for the tyrosine kinase inhibitor afatinib in mouse plasma using salting-out liquid-liquid extraction. 2016

Rolf W Sparidans, and Stephanie van Hoppe, and Johannes J M Rood, and Alfred H Schinkel, and Jan H M Schellens, and Jos H Beijnen
Utrecht University, Faculty of Science, Department of Pharmaceutical Sciences, Division of Pharmacoepidemiology & Clinical Pharmacology, Universiteitsweg 99, 3584CG Utrecht, The Netherlands. Electronic address: R.W.Sparidans@uu.nl.

A quantitative bioanalytical liquid chromatography-tandem mass spectrometric (LC-MS/MS) assay for afatinib, an irreversible inhibitor of the ErbB (erythroblastic leukemia viral oncogene homolog) tyrosine kinase family, was developed and validated. Plasma samples were pre-treated using salting-out assisted liquid-liquid extraction (SALLE) with acetonitrile, magnesium chloride and a stable isotopically labeled internal standard. After dilution, the extract was directly injected into the reversed-phase liquid chromatographic system. The eluate was transferred into the electrospray interface with positive ionization and compounds were detected in the selected reaction monitoring mode of a triple quadrupole mass spectrometer. The assay was completely validated for plasma in a 0.5-500ng/ml calibration range with r(2)=0.995±0.002 (n=6) using linear regression with the inverse square of the concentration as the weighting factor for the calibration. Within-run precisions (n=18) were 2.7-11.7% and between-run (3 runs; n=18) precisions 3.0-14.5%. Accuracies were between 96-109% for the whole calibration range. The drug was sufficiently stable under all relevant analytical conditions. Finally, the assay was successfully applied to determine plasma drug levels and study pharmacokinetics after oral administration of afatinib to female FVB mice.

UI MeSH Term Description Entries
D011799 Quinazolines A group of aromatic heterocyclic compounds that contain a bicyclic structure with two fused six-membered aromatic rings, a benzene ring and a pyrimidine ring. Quinazoline
D002853 Chromatography, Liquid Chromatographic techniques in which the mobile phase is a liquid. Liquid Chromatography
D005260 Female Females
D000077716 Afatinib A quinazoline and butenamide derivative that acts as a tyrosine kinase inhibitor of epidermal growth factor receptors (ERBB RECEPTORS) and is used in the treatment of metastatic NON-SMALL CELL LUNG CANCER. (2E)-N-(4-(3-Chloro-4-fluoroanilino)-7-(((3S)-oxolan-3-yl)oxy)quinoxazolin-6-yl)-4-(dimethylamino)but-2-enamide,Afatinib Dimaleate,Afatinib Maleate,BIBW 2992,BIBW-2992,BIBW-2992-MA2,BIBW-2992MA2,BIBW2992,BIBW2992 MA2,Gilotrif,BIBW 2992 MA2,BIBW 2992MA2
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face
D016014 Linear Models Statistical models in which the value of a parameter for a given value of a factor is assumed to be equal to a + bx, where a and b are constants. The models predict a linear regression. Linear Regression,Log-Linear Models,Models, Linear,Linear Model,Linear Regressions,Log Linear Models,Log-Linear Model,Model, Linear,Model, Log-Linear,Models, Log-Linear,Regression, Linear,Regressions, Linear
D047428 Protein Kinase Inhibitors Agents that inhibit PROTEIN KINASES. Protein Kinase Inhibitor,Inhibitor, Protein Kinase,Inhibitors, Protein Kinase,Kinase Inhibitor, Protein,Kinase Inhibitors, Protein
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D053719 Tandem Mass Spectrometry A mass spectrometry technique using two (MS/MS) or more mass analyzers. With two in tandem, the precursor ions are mass-selected by a first mass analyzer, and focused into a collision region where they are then fragmented into product ions which are then characterized by a second mass analyzer. A variety of techniques are used to separate the compounds, ionize them, and introduce them to the first mass analyzer. For example, for in GC-MS/MS, GAS CHROMATOGRAPHY-MASS SPECTROMETRY is involved in separating relatively small compounds by GAS CHROMATOGRAPHY prior to injecting them into an ionization chamber for the mass selection. Mass Spectrometry-Mass Spectrometry,Mass Spectrometry Mass Spectrometry,Mass Spectrometry, Tandem

Related Publications

Rolf W Sparidans, and Stephanie van Hoppe, and Johannes J M Rood, and Alfred H Schinkel, and Jan H M Schellens, and Jos H Beijnen
September 2017, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Rolf W Sparidans, and Stephanie van Hoppe, and Johannes J M Rood, and Alfred H Schinkel, and Jan H M Schellens, and Jos H Beijnen
January 2014, Journal of pharmaceutical and biomedical analysis,
Rolf W Sparidans, and Stephanie van Hoppe, and Johannes J M Rood, and Alfred H Schinkel, and Jan H M Schellens, and Jos H Beijnen
December 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Rolf W Sparidans, and Stephanie van Hoppe, and Johannes J M Rood, and Alfred H Schinkel, and Jan H M Schellens, and Jos H Beijnen
September 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Rolf W Sparidans, and Stephanie van Hoppe, and Johannes J M Rood, and Alfred H Schinkel, and Jan H M Schellens, and Jos H Beijnen
September 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Rolf W Sparidans, and Stephanie van Hoppe, and Johannes J M Rood, and Alfred H Schinkel, and Jan H M Schellens, and Jos H Beijnen
April 2013, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Rolf W Sparidans, and Stephanie van Hoppe, and Johannes J M Rood, and Alfred H Schinkel, and Jan H M Schellens, and Jos H Beijnen
May 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Rolf W Sparidans, and Stephanie van Hoppe, and Johannes J M Rood, and Alfred H Schinkel, and Jan H M Schellens, and Jos H Beijnen
January 2014, Journal of pharmaceutical and biomedical analysis,
Rolf W Sparidans, and Stephanie van Hoppe, and Johannes J M Rood, and Alfred H Schinkel, and Jan H M Schellens, and Jos H Beijnen
October 2014, Biomedical chromatography : BMC,
Rolf W Sparidans, and Stephanie van Hoppe, and Johannes J M Rood, and Alfred H Schinkel, and Jan H M Schellens, and Jos H Beijnen
March 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Copied contents to your clipboard!